Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | AZN | AMGN | GILD | VRTX |
| Company | Inhibrx Biosciences Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 84.20 | 90.62 | 317.89 | 122.25 | 445.65 |
| High | 87.60 | 91.52 | 320.19 | 123.74 | 448.33 |
| Low | 83.00 | 90.44 | 312.39 | 121.00 | 442.07 |
| Latest | 84.32 | 90.67 | 315.51 | 123.50 | 445.60 |
| Change | -0.19 | -0.84 | +0.13 | +2.16 | +0.96 |
| % Change | -0.22% | -0.92% | +0.04% | +1.78% | +0.22% |
| Volume | 79,304 | 4,603,493 | 1,183,476 | 2,619,486 | 566,203 |
| 20-Day Average Volume | 244,184 | 5,539,275 | 2,852,326 | 7,059,719 | 1,353,449 |
| Previous Close | 84.51 | 91.51 | 315.38 | 121.34 | 444.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 83.01 | 90.55 | 334.88 | 124.47 | 436.77 |
| 20-Day Raw Stochastic | 54.65% | 45.56% | 10.11% | 47.30% | 60.61% |
| 20-Day Relative Strength | 61.21 | 57.52 | 46.68 | 52.45 | 57.11 |
| Weighted Alpha | +322.12 | +39.32 | +16.63 | +32.28 | -0.23 |
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.58% since 12/04/25 | +0.56% since 12/04/25 | -7.11% since 12/04/25 | +0.69% since 12/04/25 | -2.48% since 12/04/25 |
| Low | 79.00 on 12/10/25 | 89.67 on 12/08/25 | 312.55 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 94.47 on 12/08/25 | 91.66 on 12/10/25 | 340.88 on 12/05/25 | 123.73 on 12/11/25 | 462.00 on 12/05/25 |
| 1-Month | |||||
| %Chg | +8.27% since 11/11/25 | +1.62% since 11/11/25 | -6.64% since 11/11/25 | +0.74% since 11/11/25 | +3.91% since 11/11/25 |
| Low | 72.00 on 11/13/25 | 87.23 on 11/12/25 | 312.55 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 94.47 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +196.24% since 09/11/25 | +11.63% since 09/11/25 | +11.76% since 09/11/25 | +4.76% since 09/11/25 | +12.24% since 09/11/25 |
| Low | 26.19 on 09/17/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 94.47 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +474.11% since 06/11/25 | +22.77% since 06/11/25 | +8.28% since 06/11/25 | +12.96% since 06/11/25 | -1.42% since 06/11/25 |
| Low | 13.92 on 06/12/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 94.47 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,229,113 | 283,811,488 | 169,826,144 | 150,544,112 | 112,813,616 |
| Shares Outstanding, K | 14,544 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 200,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 1,687,570,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,300,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -28,650,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.18 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.28 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/16/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.65 | 14.35 | 14.57 | 28.54 |